Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand

Wells Fargo cut its price target for Fidelity National Information Services (FIS) to $46 from $58, citing concerns over the Capital Markets segment. Despite this, no analysts rate FIS a sell, and the stock trades at a 23% discount to the mean target. FIS raised its free cash flow guidance for 2026 to $2.15B-$2.25B, up 36% at the midpoint. The stock closed at $41.40 on August 24, 2026.

Palantir Technologies (PLTR) announced that its Maven Smart System, an AI-powered military platform, has been designated an official Pentagon program of record. This designation could secure $2.3 billion in funding over five years. Maven analyzes battlefield data and supports AI-enabled targeting, making it a key tool for the U.S. military. Palantir's government contracts, including Maven, contributed significantly to its revenue, with $809 million from U.S. government contracts in Q2, up 90% ye

Hormel Foods appointed Ash Bhumbla, a former Tyson Foods executive, as its new CFO, effective September. Bhumbla succeeds Paul Kuehneman, who will remain a senior leader. Hormel reported strong Q2 results and is set to release Q3 earnings on Thursday, according to the company.

Equinor (EQNR) began its Troll Phase 3 stage 2 subsea project earlier than planned, with costs below the NOK12.3B ($1.32B) estimate. The project was initially expected to start later in the year.

UBS Securities downgraded Fluence Energy to 'Neutral' from 'Sell' with a $12 price target, citing a more balanced risk-reward profile. The stock is currently at $11.36, up 4.65% on the day but down 3.28% year-to-date and 42.54% over 5 days.

Raymond James upgraded AMD stock to strong buy from outperform, citing increased demand for CPUs in AI workloads. Analyst Simon Leopold highlighted the growing importance of CPUs in AI infrastructure.